STEM CELL THERAPY: with DR ANDREW J. ROCHMAN
Dr. Andrew J Rochman is a leader in advanced surgical techniques, a native New Yorker and a Board-Certified Surgeon. His current undertaking involves promoting an educational advocacy in MODERN...
By: Modern Pain Relief
Read more from the original source:
STEM CELL THERAPY: with DR ANDREW J. ROCHMAN - Video
How can you get the best result after stem cell therapy for autism spectrum disorder
How can you get the best result after stem cell therapy for autism spectrum disorder? In conversation with Dr Alok Sharma (MS, MCh.) Professor of Neurosurgery Head of Department, LTMG Hospital...
By: Neurogen Brain and Spine Institute
Read this article:
How can you get the best result after stem cell therapy for autism spectrum disorder - Video
Update On Stem Cell Research
Regenerative medicine and stem cell technology is revolutionizing the medical field. Kristin Comella, Chief Science Officer for Bioheart (BHRT), explains the growth of the industry and the potential.
By: Bioheart Inc.
See the article here:
Update On Stem Cell Research - Video
Learn about Bioheart Inc. (BHRT)
Kristin Comella, Chief Science Officer for Bioheart (BHRT), discusses the company #39;s research using stem cell technology and regenerative medicine products.
By: Bioheart Inc.
Read more:
Learn about Bioheart Inc. (BHRT) - Video
ABC Kellie van Meurs (3rd from R) died of a heart attack last month while receiving stem cell treatment in Moscow.
The death of an Australian woman undergoing stem cell therapy in Russia has prompted a leading stem cell research group to warn of rogue operators charging thousands of dollars for ineffectual treatments.
Brisbane mother Kellie van Meurs died of a heart attack last month while receiving stem cell treatment in Moscow for her rare neurological condition known as stiff person syndrome.
Stem Cells Australia said there was a growing number of patients going overseas for stem cell treatments which are limited in Australia.
A loophole in the therapeutic goods legislation means that doctors are legally allowed to treat patients, both here and overseas, with their own stem cells even if the treatment is unsafe or has not been proven effective through clinical trials.
Stem Cells Australia said it believed dozens of doctors in Australia offered the questionable treatments.
"They're selling treatment without any proof of benefit, and without any proof of safety," Associate Professor Megan Munsie, a stem cell biologist at the University of Melbourne, told the 7.30 program.
Annie Leverington was diagnosed with multiple sclerosis in 2007.
She was once a talented flamenco dancer and worked as a court stenographer.
But in 2002 she noticed something was wrong when her fingers started to "drop" during long trials.
More here:
Rogue stem cell therapy operators charging thousands for ineffective treatments, researchers say
Why not embryonic stem cell
Why not embryonic stem cell ? In conversation with Dr Alok Sharma (MS, MCh.) Professor of Neurosurgery Head of Department, LTMG Hospital LTM Medical College, Sion, Mumbai. Stem Cell Therapy...
By: Neurogen Brain and Spine Institute
Visit link:
Why not embryonic stem cell - Video
LUMINESCE Stem cell Therapy Dr Nathan Newman
LUMINESCE Stem Cell Technology by JEUNESSE created from Telomere Research. Order Now: http://www.evenyounger.jeunesseglobal.com/PersonalCare.aspx?id=1.
By: Even Younger
See the original post:
LUMINESCE Stem cell Therapy Dr Nathan Newman - Video
Stem Cells Simply Explained
Stem Cells Explanation Video.
By: Addam Smith
Continued here:
Stem Cells Simply Explained - Video
Djuana Testimonial Twilight Face Lift with Stem Cells
This video is about djuana testimonial twilight.
By: Tammy Tucker
See the original post:
Djuana Testimonial Twilight Face Lift with Stem Cells - Video
Jerad Temple ALS Ice Bucket Challenge
Thanks to McKenna Simonelli for the nomination. Donating to Pope John Paul II Medical Research because they only use adult stem cells in their research.
By: Jerad Temple
Read the rest here:
Jerad Temple ALS Ice Bucket Challenge - Video
46 2 Ning -spinal cord injury of C4-C5 (male, 26-year-old) - After stem cell treatment
Ning, a 26-year-old guy, happened to fall down from a high level in September, 2006, which led to his spinal cord injury of C4-C5 and remained quadriplegia, incontinence of urination and bowl...
By: Stem Cells
See the original post here:
46 2 Ning -spinal cord injury of C4-C5 (male, 26-year-old) - After stem cell treatment - Video
46 1 Ning -spinal cord injury of C4-C5 (male, 26-year-old) - Before stem cell treatment
Ning, a 26-year-old guy, happened to fall down from a high level in September, 2006, which led to his spinal cord injury of C4-C5 and remained quadriplegia, incontinence of urination and bowl...
By: Stem Cells
Read the rest here:
46 1 Ning -spinal cord injury of C4-C5 (male, 26-year-old) - Before stem cell treatment - Video
52 1 Mr. Wu -Lumbar Vertebra Injury (male, 22-year-old) - Before stem cell treatment
Mr. Wu, 22 years old, happened to fall down on June 9th, 2011, which led to the 1st Lumbar vertebra injury. He received physical rehabilitation therapy after the injury, but the achieved improvemen...
By: Stem Cells
Follow this link:
52 1 Mr. Wu -Lumbar Vertebra Injury (male, 22-year-old) - Before stem cell treatment - Video
31 2 Mrs. Han -C4-C6 Spinal Cord Injury (Female, 39-year-old) - After stem cell treatment
Mrs. Han, 39 years old, suffered from movement dysfunction, sensation disorder over 1 year after C4-C6 spinal cord injury. She received 1st round stem cell treatment in our hospital in November,...
By: Stem Cells
Continued here:
31 2 Mrs. Han -C4-C6 Spinal Cord Injury (Female, 39-year-old) - After stem cell treatment - Video
Critical transport: Bond LSC team finds boron vital for plant stem cells, corn reproduction
Tiny amounts of boron play a key part in the development of ears and tassels on every cornstalk. The journal Plant Cell published research from the lab of Paula McSteen in its July 2014 edition,...
By: mubondlsc
View original post here:
Critical transport: Bond LSC team finds boron vital for plant stem cells, corn reproduction - Video
Targeting Cancer Stem Cells for Durable Response
Jonathan Pachter, PhD.
By: The Oncologist Journal
Read more here:
Targeting Cancer Stem Cells for Durable Response - Video
STEM CELL THERAPY CONCERTO
HEALING is the inevitable objective of stem cell rejuvenation, which is just beautiful integrative with time proven treatments such as acupuncture and entrenched with social science for the...
By: Leong Lau
See the original post:
STEM CELL THERAPY CONCERTO - Video
what is the procedure of stem cell therapy for autism spectrum disorder
What is the procedure of stem cell therapy for autism spectrum disorder? In conversation with Dr Alok Sharma (MS, MCh.) Professor of Neurosurgery Head of Department, LTMG Hospital LTM Medical...
By: Neurogen Brain and Spine Institute
More here:
what is the procedure of stem cell therapy for autism spectrum disorder - Video
Novartis ( NVS ) recently entered into an investment and option agreement with Israel-based Gamida Cell, a company which focuses on stem cell expansion technologies and therapeutic products.
As per the terms of the agreement, Novartis will invest $35 million in Gamida Cell. In exchange, Novartis will receive a 15% stake in Gamida Cell and an option to fully acquire the company.
The option for full acquisition is exercisable for a limited period of time following achievement of certain milestones in connection with the development of pipeline candidate, NiCord. These milestones are expected to be achieved during 2015. Novartis will also be required to pay the other shareholders in Gamida Cell approximately $165 million upon exercising the option along with potential milestone payments of $435 million.
We note that Gamida Cell is developing stem cell therapy for the potential treatment of blood cancers, solid tumors, non-malignant hematological diseases such as sickle cell disease and thalassemia, neutropenia and acute radiation syndrome, autoimmune diseases and genetic metabolic diseases as well as conditions that can be helped by regenerative medicine.
The company is currently evaluating NiCord for the potential treatment of hematological malignancies such as leukemia and lymphoma in a phase I/II study using its proprietary NAM technology.
Meanwhile, enrolment is on for the company's phase I/II study on NiCord for pediatric sickle cell disease.
We remind investors that Novartis has been taking strategic steps to realign its portfolio in order to focus on its core portfolio of pharmaceuticals, eye care and generics. Novartis' recent deal to acquire oncology products from GlaxoSmithKline ( GSK ) and the divestiture of the Vaccines business is a step in the right direction.
Novartis, a large-cap pharma, currently carries a Zacks Rank #3 (Hold). Right now, Allergan ( AGN ) and AbbVie ( ABBV ) look well positioned among the large-cap pharmas. While Allergan carries a Zacks Rank #1 (Strong Buy), AbbVie is a Zacks Rank #2 (Buy) stock.
NOVARTIS AG-ADR (NVS): Free Stock Analysis Report
ABBVIE INC (ABBV): Free Stock Analysis Report
Read the original here:
Novartis to Invest $35M in Gamida Cell for 15% Equity - Analyst Blog
(PRWEB UK) 21 August 2014
The success of stem cell medicine does not depend on funding alone
Funding is of the upmost importance but access to the right material is vital.
Stem Cell Banking of a childs own stem cells for potentially a lifetime of use, is a way of storing their health for their future. So it is vital that the right stem cells are available for treatment when they are needed at any time in their life.
Tony Veverka, Group CEO of specialist stem cell bank BioEden says, "Funding is of the upmost importance so that research can continue, but access to the right material is vital."
Gaining access to the right material for stem cell therapy has dramatically simplified since BioEden pioneered an entirely non-invasive method of taking stem cells from children's baby teeth. No longer is there just the option of stem cells from embryos, bone marrow or cord blood, but the option of taking quality cells from the baby tooth after it has fallen out naturally.
BioEden believes it can cut NHS funding dramatically by individuals banking their own stem cells, and they continue to call for clarity and transparency so that a prolonged and healthier life is accessible to all. http://www.thetimes.co.uk/tto/business/industries/health/article4181168.ece
Read this article:
The Times Have Published Only Half the Story, Says Specialist Stem Cell Bank BioEden